đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
This study will assess the impact on nasopharyngeal carriage, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-09
Trial ID
NCT01262872
Evaluate lot-to-lot consistency, safety and reactogenicity of 3 doses of GS...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-11
Trial ID
NCT00307554
Treatments Being Tested
This study is designed to 1) describe the safety, tolerability, and immunog...
Status
Completed
Location
Bliss Healthcare Services ( Site 0010)
Start Date
2018-07-06
Trial ID
NCT03480802
Treatments Being Tested
This study is designed to evaluate in a controlled manner the effect of Pre...
Status
Completed
Location
Multiple Locations
Start Date
2003-10
Trial ID
NCT00772928
This is a study to evaluate the immunogenicity and safety of GSK Biological...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-09-11
Trial ID
NCT00197002
Treatments Being Tested
This PMS study aims to collect safety and reactogenicity data of Synflorixâ˘...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01803425
Treatments Being Tested